Aquatic Capital Management LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1803916 CHICAGO, IL

Position in NTLA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,220,412

+$556,510 QoQ

Shares Held

95,196

+28.9% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. NTLA ranks #31 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	147,379	$11,066,689
2	ALNY	Alnylam Pharmaceuticals, Inc.	31,061	$10,277,153
3	EXEL	Exelixis, Inc.	194,571	$8,345,150
4	RPRX	Royalty Pharma plc	127,227	$6,103,079
5	ARWR	Arrowhead Pharmaceuticals, Inc.	80,227	$5,030,232
6	CYTK	Cytokinetics Inc	72,478	$4,777,024
7	XENE	Xenon Pharmaceuticals Inc.	79,199	$4,605,421
8	NKTR	Nektar Therapeutics	57,014	$4,102,157

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,220,412	95,196	+28.9%	Shares	Sole	2026-05-15
2025-12-31	$663,902	73,849	-59.5%	Shares	Sole	2026-02-17
2024-12-31	$2,127,180	182,434	+98.7%	Shares	Sole	2025-02-14
2024-09-30	$1,886,490	91,800	+300.9%	Shares	Sole	2024-11-14
2024-06-30	$512,502	22,900	+0.4%	Shares	Sole	2024-08-14
2023-12-31	$695,172	22,800	+145.2%	Shares	Sole	2024-02-14
2023-09-30	$294,066	9,300	+151.4%	Shares	Sole	2023-11-14
2023-06-30	$150,886	3,700	-14.0%	Shares	Sole	2023-08-14
2023-03-31	$160,261	4,300	-78.6%	Shares	Sole	2023-05-15
2022-12-31	$701,289	20,100	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.